Biotage AB Mutual Funds

Health Care & Life Sciences » Biotechnology | Biotage AB

Biotage AB | Mutual Funds

Mutual Funds that own Biotage AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Swedbank Robur Ny Teknik

5,005,647

7.74%

2.77%

07/31/2018

Fjarde AP Fonden

3,793,548

5.86%

3,793,548

0.13%

12/31/2016

ODIN Sverige

1,500,000

2.31%

1.83%

08/31/2018

Allianz Institutional Investors Series - European Micro Cap

1,052,741

1.63%

3.35%

05/31/2018

Government Pension Fund - Global (The)

927,110

1.43%

-184,823

12/31/2017

Tredje AP Fonden

700,028

1.08%

-70,153

0.03%

06/30/2017

DFA International Small Cap Value Portfolio

563,944

0.87%

-58,368

0.05%

04/30/2018

Credit Suisse Equity Fund (Lux) - Small & Mid Cap Europe

342,540

0.53%

3.76%

06/29/2018

DFA Continental Small Company Series

305,541

0.47%

0.07%

01/31/2018

Montanaro European Smaller Companies Trust Plc

300,000

0.46%

1.61%

07/31/2018

About Biotage AB

View Profile

Address	Vimpelgatan 5 Uppsala UP 753 18 Sweden
Employees	-
Website	http://www.biotage.com
Updated	07/08/2019
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products include equipment for chromatography and purification, organic synthesis, analytical sample preparation, evaporation and concentration, peptide synthesis, and custom projects. The company was founded by Pal Nyrén, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Björn Ekström in 1997 and is headquartered in Uppsala, Sweden.